Skip to main
ESPR
ESPR logo

Esperion Therapeutics (ESPR)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Esperion Therapeutics (ESPR) Stock

About Esperion Therapeutics (ESPR)

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, Da...read more
Market cap$757.83M
Today's volume13.07M
Revenue (TTM)$303.8M
Avg. daily volume6.99M
EBITDA (TTM)
Open$3.28
Price / earnings ratio-5.92x
Today's range$3.28 - $3.77
Debt / equity
52 week range$0.69 - $3.94
5 year debt / equity-201.71x
Beta (LTM)1.3x
Interest coverage0.92x
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMar 3, 2026
Dividend payable date

Esperion Therapeutics Stock Rating

What analysts recommend for ESPR stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 29%
Buy 57%
Hold 14%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Nov 24, 2025, the market cap for ESPR stock is $757.83M

The current P/E ratio for ESPR stock is -5.92

The 52-week high for ESPR stock is $3.94. The current ESPR stock price $undefined is 100.00% below its 52-week high

The 52-week low for ESPR stock is $0.69. The current ESPR stock price $undefined has increased 100.00% from its 52-week low

No, the ESPR stock does not pay dividends to its shareholders

The target price for ESPR stock is $6.86 based on the average of what a group of analyst think ESPR stock could be worth at a future date. This is not a prediction by Public.com

How to buy ESPR stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ESPR stock

    Navigate to the Explore page. Then, type ESPR into the search bar. When you see ESPR stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ESPR stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Esperion Therapeutics Stock Earnings

The value each ESPR share was expected to gain vs. the value that each ESPR share actually gained.

Esperion Therapeutics (ESPR) reported Q3 2025 earnings per share (EPS) of -$0.16, missing estimates of -$0.07 by 128.57%. In the same quarter last year, Esperion Therapeutics's earnings per share (EPS) was -$0.15. Esperion Therapeutics is expected to release next earnings on 03/03/2026, with an earnings per share (EPS) estimate of $0.18.

Buy Esperion Therapeutics (ESPR) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.